Molbio Diagnostics: Listed at Rs 980, a 21.4% premium over IPO price of Rs 807, marking a strong D-Street debut after 70x subscription IPCA Laboratories: Up 9% after strong Q1 results showed margins expanding to 24% from 18% year-on-year, outperforming the broader market Physicswallah: Gained 8% as Q1 revenue surged 24% to Rs 1,054 crore, though stock remains down 19% year-to-date Cemindia Projects: Rose 5% at open, up 77%...
